ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 5 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2012. The put-call ratio across all filers is 3.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $13,000 | 0.0% | 8,831 | 0.0% | 0.00% | – |
Q4 2016 | $13,000 | -13.3% | 8,831 | 0.0% | 0.00% | – |
Q3 2016 | $15,000 | 0.0% | 8,831 | 0.0% | 0.00% | – |
Q2 2016 | $15,000 | -11.8% | 8,831 | 0.0% | 0.00% | – |
Q1 2016 | $17,000 | 0.0% | 8,831 | 0.0% | 0.00% | – |
Q4 2015 | $17,000 | +183.3% | 8,831 | +203.8% | 0.00% | – |
Q3 2015 | $6,000 | -25.0% | 2,907 | +66.4% | 0.00% | – |
Q2 2015 | $8,000 | 0.0% | 1,747 | 0.0% | 0.00% | – |
Q1 2015 | $8,000 | -97.3% | 1,747 | -96.5% | 0.00% | -100.0% |
Q4 2013 | $293,000 | -30.6% | 50,000 | -37.5% | 0.01% | -33.3% |
Q3 2013 | $422,000 | -31.5% | 80,000 | 0.0% | 0.02% | -31.8% |
Q2 2013 | $616,000 | -6.2% | 80,000 | 0.0% | 0.02% | -4.3% |
Q1 2013 | $657,000 | -30.6% | 80,000 | -23.8% | 0.02% | -37.8% |
Q4 2012 | $947,000 | +137.3% | 105,000 | +118.8% | 0.04% | +131.2% |
Q3 2012 | $399,000 | -16.7% | 48,000 | 0.0% | 0.02% | -23.8% |
Q2 2012 | $479,000 | +122.8% | 48,000 | -31.4% | 0.02% | +110.0% |
Q1 2012 | $215,000 | – | 70,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 1,281,400 | $6,753,000 | 3.37% |
Perceptive Advisors | 5,116,200 | $26,962,000 | 1.11% |
SAMLYN CAPITAL, LLC | 2,266,565 | $11,945,000 | 0.33% |
Tradeworx Inc. | 132,839 | $700,000 | 0.32% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,216,579 | $6,411,000 | 0.30% |
Lyons Wealth Management, LLC. | 56,775 | $299,000 | 0.27% |
DIALECTIC CAPITAL MANAGEMENT, LP | 125,000 | $659,000 | 0.15% |
Schonfeld Group Holdings LLC | 11,400 | $60,000 | 0.12% |
DIALECTIC CAPITAL MANAGEMENT, LP | 70,000 | $369,000 | 0.08% |
ELLINGTON MANAGEMENT GROUP LLC | 72,000 | $379,000 | 0.07% |